Alcidion news and updates

Alcidion's Miya Precision Concept Detection is now registered as a Class I medical device on the Australian Register of Therapeutic Goods (ARTG 522634) and with the UK's MHRA. The AI feature, part of the Miya Noting module, reads clinicians' free text notes, identifies medical concepts and suggests SNOMED CT codes for the clinician to review. It will be offered as an optional module running on Alcidion's Miya AI Service.

Our read

Hospitals in Australia and the NHS increasingly require medical device registration before adopting AI in clinical documentation, and this clears that bar for Miya customers. Class I is the lowest risk class, so the registration speaks to process rather than clinical performance.

Alcidion's Miya Precision 7.11.0 adds a native inpatient admissions workflow, completing its admission, transfer, leave and discharge set, with one way or two way integration to the Patient Administration System so clinicians no longer need to open the PAS. The release also adds Miya Vitals, for capturing observations on charts defined per care area such as ICU, ED and general wards with validation checks and warning thresholds, and Dynamic Fluid Balance Management, which calculates fluid restriction limits from patient weight.

Our read

Trusts running a separate PAS can manage the full inpatient encounter in Miya Precision while keeping the PAS in sync, which cuts double entry. Vitals capture is manual entry only in this release; Alcidion states capture from bedside monitors is planned for a future release.

Miya Precision 7.11.0 introduces a three tier restricted access model for patient records: full access, break glass access that requires justification via an individual PIN with audit tracking, and no access. Alcidion states the design supports NHS safeguarding principles.

Our read

Privacy and information governance teams get record level access control with an audited break glass path, which matters for restricted and safeguarding sensitive patients.